lululemon Has Likely Lost All Guidance Credibility (Rating Downgrade)

Enova: Growing 33% Without A Bank, Still Trades At 10x Earnings (Buy)

2026-10-25

Columbia Banking System: Massive Share Repurchase And A 5% Yield

2026-10-25

Ocular Therapeutix: The Drug Won, The Stock Lost, And That's The Opportunity

2026-10-25

QXO: A Complicated Capital Structure With Growth Priced In (Rating Downgrade)

2026-10-25

Vicor: Don't Get Off This Ride

2026-10-25